Apoptosis in cancer

Carcinogenesis

Volumn 21, Issue 3, 2000, Pages 485-495

  Lowe, Scott W ^a   Lin, Athena W ^a  

^a Simons Center for Quantitative Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FAS ANTIGEN; PROTEIN P53; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CANCER; CARCINOGENESIS; DRUG MECHANISM; GENE MUTATION; ONCOGENE; PRIORITY JOURNAL; REVIEW;

EID: 0034057320     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.3.485     Document Type: Review

References (169)

1. Kerr, J.F., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257.
2. Wyllie, A.H., Kerr, J.F. and Currie, A.R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-306.
3. Kerr, J.F.R., Winterford, C.M. and Harmon, B.V. (1994) Apoptosis - its significance in cancer and cancer therapy. Cancer, 73, 2013-2026, [Published erratum appears in Cancer (1994) 73, 3108.]
4. Thompson, C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
5. Tsujimoto, Y. Finger, L.R., Yunis, J., Nowell, P.C. and Croce, C.M. (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science, 226, 1097-1099.
6. Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, C.M. (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science, 228, 1440-1443.
7. Vaux, D.L., Cory, S. and Adams, J.M. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-442.
8. McDonnell, T.J., Deane, N., Platt, F.M., Nunez, G., Jaeger, U., McKearn, J.P. and Korsmeyer, S.J. (1989) bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57, 79-88.
9. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D. and Korsmeyer, S.J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-336.
10. Strasser, A., Harris, A.W., Bath, M.L. and Cory, S. (1990) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature, 348, 331-333.
11. Gross, A., McDonnell, J.M. and Korsmeyer, S.J. (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev., 13, 1899-1911.
12. Reed, J.C. (1998) Bcl-2 family proteins. Oncogene. 17, 3225-3236.
13. Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J.C. and Perucho, M. (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science, 275, 967-969.
14. Meijerink, J.P., Mensink, E.J., Wang, K., Sedlak, T.W., Sloetjes, A.W., de Witte, T., Waksman, G. and Korsmeyer, S.J. (1998) Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood, 91, 2991-2997.
15. Wallace-Brodeur, R.R. and Lowe, S.W. (1999) Clinical implications of p53 mutations. Cell Mol. Life Sci., 55, 64-75.
16. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-347.
17. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
18. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
19. Beltinger, C., Bohler, T., Schrappe, M., Ludwig, W.D. and Debatin, K.M. (1998) The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases. Klin. Padiatr., 210, 153-158.
20. Marte, B.M. and Downward, J. (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci., 22, 355-358.
21. Cantley, L.C. and Neel, B.G. (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl Acad. Sci. USA, 96, 4240-4245.
22. Jager, R., Herzer, U., Schenkel, J. and Weiher, H. (1997) Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene, 15, 1787-1795.
23. Attardi, L.D. and Jacks, T. (1999) The role of p53 in tumour suppression: lessons from mouse models. Cell Mol. Life Sci., 55, 48-63.
24. Christofori, G., Naik, P. and Hanahan, D. (1994) A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature, 369, 414-418.
25. Yin, C., Knudson, C.M., Korsmeyer, S.J. and Van Dyke, T. (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature, 385, 637-640.
26. Shibata, M.A., Liu, M.L., Knudson, M.C., Shibata, E., Yoshidome, K., Bandey, T., Korsmeyer, S.J. and Green, J.E. (1999) Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. EMBO J., 18, 2692-2701.
27. Bardeesy, N., Beckwith, J.B. and Pelletier, J. (1995) Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res., 55, 215-219.
28. McCurrach, M.E., Connor, T.M., Knudson, C.M., Korsmeyer, S.J. and Lowe, S.W. (1997) bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl Acad. Sci. USA, 94, 2345-2349.
29. Soengas, M.S., Alarcon, R.M., Yoshida, H., Giaccia, A.J., Hakem, R., Mak, T.W. and Lowe, S.W. (1999) apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science, 284, 156-159.
30. Simms, L.A., Radford-Smith, G., Biden, K.G., Buttenshaw, R., Cummings, M., Jass, J.R., Young, J., Meltzer, S.J. and Leggett, B.A. (1998) Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers. Oncogene, 17, 2003-2008.
31. Biggs, J.R. and Kraft, A.S. (1995) Inhibitors of cyclin-dependent kinase and cancer. J. Mol. Med., 73, 509-514.
32. Rowan, S., Ludwig, R.L., Haupt, Y., Bates, S., Lu, X., Oren, M. and Vousden, K.H. (1996) Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J., 15, 827-838.
33. Friedlander, P., Haupt, Y., Prives, C. and Oren, M. (1996) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell Biol., 16, 4961-4971.
34. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J. and Evan, G. (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature, 385, 544-548.
35. Raff, M.C. (1992) Social controls on cell survival and cell death. Nature, 356, 397-400.
36. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80, 293-299.
37. Ziegler, A., Jonason, A.S., Leffell, D.J., Simon, J.A., Sharma, H.W., Kimmelman, J., Remington, L., Jacks, T. and Brash, D.E. (1994) Sunburn and p53 in the onset of skin cancer Nature, 372, 773-776.
38. Graeber, T.G., Osmanian, C., Jacks, T., Housman, D.E., Koch, C.J., Lowe, S.W. and Giaccia, A.J. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
39. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. and de Lange, T. (1999) p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science, 283, 1321-1325.
40. Chin, L., Artandi, S.E., Shen, Q., Tam, A., Lee, S.L., Gottlieb, G.J., Greider, C.W. and DePinho, R.A. (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 97, 527-538.
41. Frisch, S.M. and Francis, H. (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol., 124, 619-626.
42. Giancotti, F.G. and Ruoslahti, E. (1999) Integrin signaling. Science, 285, 1028-1032.
43. Nikiforov, M.A., Hagen, K., Ossovskaya, V.S., Connor, T.M., Lowe, S.W., Deichman, G.I. and Gudkov, A.V. (1996) p53 modulation of anchorage independent growth and experimental metastasis. Oncogene, 13, 1709-1719.
44. Sierra, A., Castellsague, X., Tortola, S., Escobedo, A., Lloveras, B., Peinado, M.A., Moreno, A. and Fabra, A. (1996) Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer. Clin. Cancer Res., 2, 1887-1894.
45. Popescu, R.A., Lohri, A., de Kant, E., Thiede, C., Reuter, J., Herrmann, R. and Rochlitz, C.F. (1998) bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer. Eur. J. Cancer, 34, 1268-1273.
46. Ashkenazi, A. and Dixit, V.M. (1998) Death receptors: signaling and modulation. Science, 281, 1305-1308.
47. Takeuchi, M., Rothe, M. and Goeddel, D.V. (1996) Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem., 271, 19935-19942.
48. Yeh, W.C., Pompa, J.L., McCurrach, M.E., Shu, H.B., Elia, A.J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., El-Deiry, W.S., Lowe, S.W., Goeddel, D.V. and Mak, T.W. (1998) FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science, 279, 1954-1958.
49. Green, D.R. and Reed, J.C. (1998) Mitochondria and apoptosis. Science, 281, 1309-1312.
50. Muchmore, S.W., Sattler, M., Liang, H., Meadows, R.P, Harlan, J.E., Yoon, H.S., Nettesheim, D., Chang, B.S., Thompson, C.B., Wong, S.L., Ng, S.L. and Fesik, S.W. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature, 381, 335-341.
51. Tsujimoto, Y. (1998) Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria?' Genes Cells, 3, 697-707.
52. Zou, H., Henzel, W.J., Liu, X., Lulschg, A. and Wang, X. (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90, 405-413.
53. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S. and Wang, X. (1997) Cytochrome e and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-489.
54. Srinivasula, S.M., Ahmad, M., Fernandes-Alnemri, T. and Alnemri, E.S. (1998) Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell, 1, 949-957.
55. Thornberry, N.A. and Lazebnik, Y. (1998) Caspases: enemies within. Science, 281, 1312-1316.
56. HU, Y., Benedict, M.A., Wu, D., Inohara, N. and Nunez, G. (1998) Bel-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl Acad. Sci. USA, 95, 4386-4391.
57. Muzio, M., Stockwell, B.R., Stennicke, H.R., Salvesen, G.S. and Dixit, V.M. (1998) An induced proximity model for caspase-8 activation. J. Biol. Chem., 273, 2926-2930.
58. Yang, X., Chang, H.Y. and Baltimore, D. (1998) Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. Science, 281, 1355-1357.
59. Xiang, J., Chao, D.T. and Korsmeyer, S.J. (1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl Acad. Sci. USA, 93, 14559-14563.
60. McCarthy, N.J., Whyte, M.K., Gilbert, C.S. and Evan, G.I. (1997) Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol., 136, 215-227.
61. Woo, M., Hakem, R., Soengas, M.S., Duncan, G.S., Shahinian, A., Kagi, D., Hakem, A., McCurrach, M., Khoo, W., Kaufmann, S.A., Senaldi, G., Howard, T., Lowe, S.W. and Mak, T.W. (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev., 12, 806-819.
62. Hakem, R., Hakem, A., Duncan, G.S., Henderson, J.T., Woo, M., Soengas, M.S., Elia, A., de la Pompa, J.L., Kagi, D., Khoo, W., Potter, J., Yoshida, R., Kaufman, S.A., Lowe, S.W., Penninger, J.M. and Mak, T.W. (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell, 94, 339-352.
63. Kuida, K., Haydar, T.F., Kuan, C.Y., Gu, Y., Taya, C., Karasuyama, H., Su, M.S., Rakic, P. and Flavell, R.A. (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell, 94, 325-337.
64. Yoshida, H., Kong, Y.Y., Yoshida, R., Elia, A.J., Hakem, A., Hakem, R., Penninger, J.M. and Mak, T.W. (1998) Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell, 94, 739-750.
65. Cecconi, F., Alvarez-Bolado, G., Meyer, B.I., Roth, K.A. and Gruss, P. (1998) Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell, 94, 727-737.
66. Wang, J., Zheng, L., Lobito, A., Chan, F.K., Dale, J., Sneller, M., Yao, X., Puck, J.M., Straus, S.E. and Lenardo, M.J. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell, 98, 47-58.
67. Schwartz, S.Jr, Yamamoto, H., Navarro, M., Maestro, M., Reventos, J. and Perucho, M. (1999) Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res., 59, 2995-3002.
68. Wang, Z., Sicinski,P., Weinberg, R.A., Zhang, Y. and Ravid, K. (1996) Characterization of the mouse cyclin D3 gene: exon/intron organization and promoter activity. Genomics, 35, 156-163.
69. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R. and Nunez, G. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 278, 687-689.
70. Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F., Stanbridge, E., Frisch, S. and Reed, J.C. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-1321.
71. Myers, M.P., Pass, I., Batty, I.H., Van der Kaay, J., Stolarov, J.P., Hemmings, B.A., Wigler, M.H., Downes, C.P. and Tonks, N.K. (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl Acad. Sci. USA, 95, 13513-13518.
72. Maehama, T. and Dixon, J.E. (1999) PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell. Biol., 9, 125-128.
73. Wu, G.S., Burns, T.F., McDonald, E.R.r., Jiang, W., Meng, R., Krantz, I.D., Kao, G., Gan, D.D., Zhou, J.Y., Muschel, R., Hamilton, S.R., Spinner, N.B., Markowitz, S., Wu, G. and el-Deiry, W.S. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nature Genet., 17, 141-143.
74. Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L. and Korsmeyer, S.J. (1996) BID: a novel BH3 domain-only death agonist. Genes Dev., 10, 2859-2869.
75. Li, H., Zhu, H., Xu, C.J. and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94, 491-501.
76. Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K.A. and Korsmeyer, S.J. (1999) Bid-deficient mice are resistant to Fas-induced hepalocellular apoptosis. Nature, 400, 886-891.
77. Branton, P.E., Bayley, S.T. and Graham, F.L. (1985) Transformation by human adenoviruses. Binchim. Biophys. Acta, 780, 67-94.
78. White, E., Grodzicker, T. and Stillman, B.W. (1984) Mutations in the gene encoding the adenovirus early region IB 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA. J. Virol., 52, 410-419.
79. White, E. and Stillman, B. (1987) Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins. J. Virol., 61, 426-435.
80. Rao, L., Debbas, M., Sabbatini, P., Hockenbery, D., Korsmeyer, S. and White, E. (1992) The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc. Natl Acad. Sci. USA, 89, 7742-7746.
81. Evan, G. and Littlewood, T. (1998) A matter of life and cell death. Science, 281, 1317-1322.
82. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land,H., Brooks, M., Waters, C., Penn, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69, 119-128.
83. Harrington, E.A., Bennett, M.R., Fanidi, A. and Evan, G.I. (1994) c-myc-induced apoptosis in fibroblasts is inhibited by specific cylokines. EMBO J., 13, 3286-3295.
84. Bissonnette, R.P., Echeverri, F., Mahboubi, A. and Green, D.R. (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature, 359, 552-554.
85. Fanidi, A., Harrington, E.A. and Evan, G.I. (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature, 359, 554-556.
86. Amati, B., Littlewood, T.D., Evan, G.I. and Land, H. (1993) The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 12, 5083-5087.
87. Samuelson, A.V. and Lowe, S.W. (1997) Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc. Natl Acad Sci. USA, 94, 12094-12099.
88. Morgenbesser, S.D., Williams, B.O., Jacks, T. and DePinho, R.A. (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature, 371, 72-74.
89. Macleod, K.F., Hu, Y. and Jacks, T. (1996) Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J., 15, 6178-6188.
90. Haupt, Y. Rowan, S. and Oren, M. (1995) p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene, 10, 1563-1571.
91. Wu, X. and Levine, A.J. (1994) p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad Sci. USA, 91, 3602-3606.
92. Shan, B. and Lee, W.H. (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell Biol., 14, 8166-8173.
93. Qin, X.Q., Livingston, D.M., Kaelin, W.G.Jr and Adams, P.D. (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl Acad Sci. USA. 91, 10918-10922.
94. Lowe, S.W. and Ruley, H.E. (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus E1A and accompanies apoptosis. Genes Dev., 7, 535-545.
95. Lowe, S.W., Jacks, T., Housman, D.E. and Ruley, H.E. (1994) Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl Acad. Sci. USA, 91, 2026-2030.
96. Debbas, M. and White, E. (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7, 546-554.
97. Hermeking, H. and Eick, D. (1994) Mediation of c-myc induced apoptosis by p53. Science, 265, 2091-2093.
98. wafl/cipl. Genes Dev., 8, 2817-2830.
99. Pan, H.C. and Griep, A.E. (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development. Genes Dev., 8, 1285-1299.
100. Howes, K.A., Ransom, L.N., Papermaster, D.S., Lasudry, J.G.H., Albert, D.M. and Windle, J.J. (1994) Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev., 8, 1300-1310.
101. Symonds, H., Krall, L., Remington, L., Saenzrobles, M., Lowe, S., Jacks, T.and Vandyke, T. (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78, 703-711.
102. Schmitt, C.A., McCurrach, M.E., de Stanchina, E., Wallace-Brodeur, R.R. and Lowe, S.W. (1999) INK4a/ARF mutations promote lymphomagenesis and chemoresistance by disabling p53. Genes Dev., 13, 2670-2677.
103. Sherr, C.J. (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev., 12, 2984-2991.
104. Dang, C.V. (1999) c-Myc target genes involved in cell growth, apoptosis and metabolism. Mol. Cell Biol., 19, 1-11.
105. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J. and Roussel, M.F. (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev., 12, 2424-2433.
106. de Stanchina, E., McCurrach, M.E., Zindy, F., Shieh, S.Y., Ferbeyre, G., Samuelson, A.V., Prives, C., Roussel, M.F., Sherr, C.J. and Lowe, S.W. (1998) E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev., 12, 2434-2442.
107. Fearnhead, H.O., McCurrach, M.E., O'Neil, J., Zhang, K., Lowe, S.W. and Lazebnik, Y.A. (1997) Oncogene-dependent apoptosis in extracts from drug-resistant cells. Genes Dev., 11, 1266-1276.
108. Juin, P., Hueber, A.O., Littlewood, T. and Evan, G. (1999) c-myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev., 13, 1367-1381.
109. Jurgensmeier, J.M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D. and Reed, J.C. (1998) Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl Acad. Sci. USA, 95, 4997-5002.
110. Polyak, K., Xia, Y. Zweier, J.L., Kinzler, K.W. and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature, 389, 300-305.
111. Fearnhead, H.O, Rodriguez, J., Govek, E.E., Guo, W., Kobayashi, R., Hannon, G. and Lazebnik, Y.A. (1998) Oncogene-dependent apoptosis is mediated by caspase-9. Proc. Natl Acad. Sci. USA, 95, 13664-13669.
112. Searle, J., Lawson, T.A., Abbott, P.J., Harmon, B. and Kerr, J.F.R. (1975) An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J. Pathol., 116, 129-138.
113. Dive, C. and Hickman, J.A. (1991) Drug-target interactions: only the first step in the commitment to a programmed cell death? Br. J. Cancer, 64, 192-196.
114. Kaufmann, S.H. (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, amplothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49, 5870-5878.
115. Eastman, A. (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2, 275-280.
116. Schmitt, C.A. and Lowe, S.W. (1999) Apoptosis and therapy. J. Pathol., 187, 127-137.
117. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 954-967.
118. Lowe, S.W., Bodis, S., McClatchey, A., Remington, L., Ruley, H.E., Fisher, D., Housman, D.E. and Jacks, T. (1994) p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807-810.
119. Fujiwara, T., Grimm, E.A., Mukhopadhyay, T., Zhang, W.W., Owenschaub, L.B. and Roth, J.A. (1994) Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res., 54, 2287-2291.
120. Barrington, R.E., Subler, M.A., Rands, E., Omer, C.A., Miller, P.J., Hundley, J.E., Koester, S.K., Troyer, D.A., Bearss, D.J., Conner, M.W., Gibbs, J.B., Hamilton, K., Koblan, K.S., Mosser, S.D., O'Neill, T.J., Schaber, M.D., Senderak, E.T., Windle, J.J., Oliff, A. and Kohl, N.E. (1998) A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol. Cell Biol., 18, 85-92.
121. Bunz, F., Hwang, P.M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1999) Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest., 104, 263-269.
122. Miyashita, T. and Reed, J.C. (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81, 151-157.
123. Fisher, T.C., Milner, A.E., Gregory, C.D., Jackman, A.L., Aherne, G.W., Hartley, J.A., Dive, C. and Hickman, J.A. (1993) bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res., 53, 3321-3326.
124. Strasser, A., Harris, A.W., Jacks, T. and Cory, S. (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by bcl-2. Cell, 79, 329-339.
125. Friesen, C., Herr, J., Krammer, P.H. and Debatin, K.M. (1996) Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med., 2, 574-577.
126. Villunger, A. and Strasser, A. (1998) Does 'death receptor' signaling play a role in tumorigenesis and cancer therapy? Oncol. Res., 10, 541-550.
127. Heerema, N.A., Sather, H.N., Sensel, M.G., Liu-Mares, W., Lange, B.J., Bostrom, B.C, Nachman, J.B., Steinherz, P.G., Hutchinson, R., Gaynon, P.S., Arthur, D.C. and Uckun, F.M. (1999) Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. Blood, 94, 1537-1544.
128. Brown, J.M. and Wouters, B.G. (1999) Apoptosis, p53 and tumor cell sensitivity to anticancer agents. Cancer Res., 59. 1391-1399.
129. Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B. and Williams, J. (1997) Cell-cycle arrest versus cell death in cancer. Nature Med., 3, 1034-1036.
130. Walker, A., Taylor, S.T., Hickman, J.A. and Dive, C. (1997) Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells. Cancer Res., 57, 1939-1945.
131. Lotem, J. and Sachs, L. (1993) Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ., 4, 41-47.
132. Clarke, A.R., Gledhill, S., Hooper, M.L., Bird, C.C. and Wyllie, A.H. (1994) p53 dependence or early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene, 9, 1767-1773.
133. Merritt, A.J., Potten, C.S., Kemp, C.J., Hickman, J.A., Balmain, A., Lane, D.P. and Hall, P.A. (1994) The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res., 54, 614-617.
134. Pritchard, D.M., Potten, C.S. and Hickman, J.A. (1998) The relationships between p53-dependent apoptosis, inhibition of proliferation and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Rec., 58, 5453-5465.
135. Westphal, C.H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D.E. and Leder, P. (1997) atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nature Genet., 16, 397-401.
136. Domen, J., Gandy, K.L. and Weissman, I.L. (1998) Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood, 91, 2272-2282.
137. Rupnow, B.A., Murtha, A.D., Alarcon, R.M., Giaccia, A.J. and Knox, S.J. (1998) Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. Cancer Res., 58, 1779-1784.
138. Graeber, T.G., Osmanian, C., Jacks, T., Housman, D.E., Koch, C.J., Lowe, S.W. and Giaccia.A.J. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
139. Wynford-Thomas, D. (1999) Cellular senescence and cancer. J. Pathol., 187, 100-111.
140. 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev., 10, 934-947.
141. INK4a. Cell, 88, 593-602.
142. Lin, A.W., Barradas, M., Stone, J.C., van Aelst, L., Serrano, M. and Lowe, S.W. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev., 12, 3008-3019.
143. Zhu, J., Woods, D., McMahon, M. and Bishop, J.M. (1998) Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev., 12, 2997-3007.
144. wafl/cipl in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene, 18, 4808-4818.
145. Chang, B.D., Broude, E.V., Dokmanovic, M., Zhu, H., Ruth, A., Xuan, Y., Kandel, E.S., Lausch, E., Christov, K. and Roninson, J.B. (1999) A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res., 59, 3761-3767.
146. Tai, Y.T., Strobel, T., Kufe, D. and Cannistra, S.A. (1999) In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene. Cancer Res., 59, 2121-2126.
147. Sumantran, V.N., Ealovega, M.W., Nunez, G., Clarke, M.F. and Wicha, M.S. (1995) Overexpression of bcl-x(S), sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55, 2507-2510.
148. Ealovega, M.W., McGinnis, P.K., Sumantran, V.N., Clarke, M.F. and Wicha, M.S. (1996) bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Res., 56, 1965-1969.
149. Clarke, M.F., Apel, I.J., Benedict, M.A., Eipers, P.G., Sumantran, V., Gonzalez-Garcia, M., Doedens, M., Fukunaga, N., Davidson, B., Dick, J.E. et al (1995) A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc. Natl Acad. Sci. USA, 92, 11024-11028.
150. Haldar, S., Jena, N. and Croce, C.M. (1995) Inactivation of Bcl-2 by phosphorylation. Prac. Natl Acad. Sci. USA, 92, 4507-4511.
151. Wang, C.Y., Mayo, M.W. and Baldwin, A.S.Jr (1996) TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science, 274, 784-787.
152. Wang, C.Y., Cusack, J.C.Jr. Liu, R. and Baldwin, A.S.Jr (1999) Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nature Med., 5, 412-417.
153. Adams, J., Palombella, V.J., Sausville, E.A., Johnson, J., Destree, A., Lazarus, D.D., Maas, J., Pien, C.S., Prakash, S. and Elliott, P.J. (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res., 59, 2615-2622.
154. Heimbrook, D.C. and Oliff, A. (1998) Therapeutic intervention and signaling. Curr. Opin. Cell Biol., 10, 284-288.
155. Leblanc, V., Delumeau, I. and Tocque, B. (1999) Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells. Oncogene, 18, 4884-4889.
156. Spitz, F.R., Nguyen, D., Skibber, J.M., Cusack, J., Roth, J.A. and Cristiano, R.J. (1996) In vim adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Res., 16, 3415-3422.
157. Badie, B., Kramar, M.H., Lau, R., Boothman, D.A., Economou, J.S. and Black, K.L. (1998) Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors. J. Neurooncol., 37, 217-222.
158. Swisher, S.G., Roth, J.A., Nemunaitis, J., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., Connors, D.G., El-Naggar, A.K., Fossella, F., Glisson, B.S., Hong, W.K., Khuri, FR., Kurie, J.M., Lee, J.J., Lee, J.S., Mack, M., Merritt, J.A., Nguyen, D.M., Nesbitt, J.C., Perez-Soler, R., Pisters, K.M., Putnam, J.B. Jr, Richli, W.R., Savin, M., Waugh, M.K. et al. (1999) Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J. Natl Cancer Inst., 91, 763-771.
159. Wold, W.S. (1993) Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF. J. Cell Biochem., 53, 329-335.
160. Dong, J., Naito, M. and Tsuruo, T. (1997) c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells. Oncogene, 15, 639-647.
161. Pan, G., Ni, J., Wei, Y.F., Yu, G., Gentz, R. and Dixit, V.M. (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL Science, 277, 815-818.
162. Sheridan, J.P., Marsters, S.A., Pitti, R.M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C.L., Baker, K., Wood, W.I., Goddard, A.D., Godowski, P. and Ashkenazi, A., (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science, 277, 818-821.
163. Noteborn, M.H., Todd, D., Verschueren, C.A., de Gauw, H.W., Curran, W.L., Veldkamp, S., Douglas, A.J., McNulty, M.S., van der Eb, A.J. and Koch, G. (1994) A single chicken anemia virus protein induces apoptosis. J. Virol., 68, 346-351.
164. Danen-Van Oorschot, A.A., Fischer, D.F., Grimbergen, J.M., Klein, B., Zhuang, S., Falkenburg, J.H., Backendorf, C., Quax, P.H., Van der Eb, A.J. and Noteborn, M.H. (1997) Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc. Natl Acad. Sci. USA, 94, 5843-5847.
165. Noteborn, M.H.M., Zhang, Y. and van der Eb, A.J. (1998) Apoptin(R) specifically causes apoptosis in tumor cells and after UV-treatment in untransformed cells from cancer-prone individuals: A review. Mutat. Res., 400, 447-455.
166. Danen-Van Oorschot, A.A., Zhang, Y., Erkeland, S.J., Fischer, D.F., van der Eb, A.J. and Noteborn, M.H. (1999) The effect of Bcl-2 on Apoptin in 'normal' vs transformed human cells. Leukemia, 13, S75-S77.
167. Krek, W., Xu, G. and Livingston, D.M. (1995) Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell, 83, 1149-1158.
168. Chen, Y.N., Sharma, S.K., Ramsey, T.M., Jiang, L., Martin, M.S., Baker, K., Adams, P.D., Bair, K.W. and Kaelin, W.G.Jr (1999) Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc. Natl Acad. Sci. USA, 96, 4325-4329.
169. Komarov, P.G., Komarova, E.A., Kondratov, R.V, Christov-Tselkov, K., Coon, J.S., Chernov, M.V. and Gudkov, A.V. (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science, 285, 1733-1737.